The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Defects of glucose transport and phosphorylation may underlie insulin resistance in obesity and non-insulin-dependent diabetes mellitus (NIDDM). To test this hypothesis, dynamic imaging of 18F-2-deoxy-glucose uptake into midthigh muscle was performed using positron emission tomography during basal and insulin-stimulated conditions (40 mU/m2 per min), in eight lean nondiabetic, eight obese nondiabetic, and eight obese subjects with NIDDM. In additional studies, vastus lateralis muscle was obtained by percutaneous biopsy during basal and insulin-stimulated conditions for assay of hexokinase and citrate synthase, and for immunohistochemical labeling of Glut 4. Quantitative confocal laser scanning microscopy was used to ascertain Glut 4 at the sarcolemma as an index of insulin-regulated translocation. In lean individuals, insulin stimulated a 10-fold increase of 2-deoxy-2[18F]fluoro-D-glucose (FDG) clearance into muscle and significant increases in the rate constants for inward transport and phosphorylation of FDG. In obese individuals, the rate constant for inward transport of glucose was not increased by insulin infusion and did not differ from values in NIDDM. Insulin stimulation of the rate constant for glucose phosphorylation was similar in obese and lean subjects but reduced in NIDDM. Insulin increased by nearly twofold the number and area of sites labeling for Glut 4 at the sarcolemma in lean volunteers, but in obese and NIDDM subjects translocation of Glut 4 was attenuated. Activities of skeletal muscle HK I and II were similar in lean, obese and NIDDM subjects. These in vivo and ex vivo assessments indicate that impaired glucose transport plays a key role in insulin resistance of NIDDM and obesity and that an additional impairment of glucose phosphorylation is evident in the insulin resistance of NIDDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“The “glucose clamp” method (14), determines insulin sensitivity but does not separate glucose transport and phosphorylation from subsequent steps of metabolism.”
MethodSokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Phelps, M. E., Huang, S. C., Hoffman, E. J., Selin, C., Sokoloff, L., & Kuhl, D. E. (1979) · Annals of Neurology · doi:10.1002/ana.410060502 · Cited by 2,418 · cited 1×
“This modeling of PET data was originally developed and then validated for brain (23), and later validated for myocardium (24).”
MethodHamacher, K., Coenen, H. H., & Stöcklin, G. (1986) · PubMed · Cited by 1,351
Shulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248 · cited 1×
“Impairment of insulin-stimulated glycogen synthesis in NIDDM (16), does not exclude a proximal impairment of glucose transport or phosphorylation, particularly since decreased skeletal muscle [G-6-P] has also been found in NIDDM (17).”
BackgroundLaakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930 · cited 1×
“The rate constant for inward transport of glucose describes the efficiency of glucose movement from blood to tissue and insulin resistance in the stimulation of blood flow (57), or factors such as reduced capillary density (58), could potentially influence the rate constant for inward transport of glucose.”
BackgroundMolecular Biology of Mammalian Glucose Transporters
Bell, G. I., Kayano, T., Buse, J. B., Burant, C. F., Takeda, J., Lin, D., Fukumoto, H., & Seino, S. (1990) · Diabetes Care · doi:10.2337/diacare.13.3.198 · Cited by 853 · cited 1×
“The structure and expression of the insulin-regulated glucose transporter, Glut 4, is normal in most individuals with obesity or NIDDM (4–7), but insulin-regulated translocation of Glut 4 was not assessed and this is essential for functional competence of Glut 4 (8, 9).”
BackgroundCellular and molecular diversities of mammalian skeletal muscle fibers
Pette, D., & Staron, R. S. (1990) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/3540528806_3 · Cited by 798 · cited 1×
“The ratio of HK to CS enzyme activity levels, an index reflecting proportionality between glycolytic and oxidative enzyme capacities (41), was highest in NIDDM (P , 0.”
BackgroundLillioja, S., Young, A. A., Culter, C. L., Ivy, J. L., Abbott, W. G., Zawadzki, J. K., Yki-Järvinen, H., Christin, L., Secomb, T. W., & Bogardus, C. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113088 · Cited by 782 · cited 1×
“The rate constant for inward transport of glucose describes the efficiency of glucose movement from blood to tissue and insulin resistance in the stimulation of blood flow (57), or factors such as reduced capillary density (58), could potentially influence the rate constant for inward transport of glucose.”
Background
Cited by
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
“Individuals with diabetes also have a decreased rate constant for glucose phosphorylation, which is then followed by an approximately 50% reduction in both the rate of muscle glycogen synthesis and glucose oxidation (258, 259).”
BackgroundCellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
“Diabetes 51: 2944–2950, 2002 Metabolism of both glucose and fatty acids by skeletal muscle is impaired in type 2 diabetes (1,2).”
BackgroundSelf-citationMcGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
“diabetes (19). The same principle was established in obese nondiabetic and diabetic humans by Kelley et al. ( 20 ), although in this study an additional impairment of glucose phosphorylation appeared to exist in the diabetic subjects.”
BackgroundInsulin action and resistance in obesity and type 2 diabetes
Czech, M. P. (2017) · Nature Medicine · doi:10.1038/nm.4350 · Cited by 1,258
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
Ritov, V. B., Menshikova, E. V., He, J., Ferrell, R. E., Goodpaster, B. H., & Kelley, D. E. (2005) · Diabetes · doi:10.2337/diabetes.54.1.8 · Cited by 887
Self-citationMorino, K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25151 · Cited by 811
Cline, G. W., Petersen, K. F., Krssak, M., Shen, J., Hundal, R. S., Trajanoski, Z., Inzucchi, S., Dresner, A., Rothman, D. L., & Shulman, G. I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410404 · Cited by 675
Exercise and Insulin Sensitivity: A Review
Borghouts, L. B., & Keizer, H. A. (2000) · International Journal of Sports Medicine · doi:10.1055/s-2000-8847 · Cited by 597
Holmes, B. F., Kurth-Kraczek, E. J., & Winder, W. W. (1999) · Journal of Applied Physiology · doi:10.1152/jappl.1999.87.5.1990 · Cited by 489
Garvey, W. T., Maianu, L., Zhu, J. H., Brechtel-Hook, G., Wallace, P., & Baron, A. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1557 · Cited by 459
“(6), using confocal laser scanning microscopy found that insulin doubled GLUT4 label at sarcolemma.”
BackgroundMethodInfluentialSimoneau, J.-A., & Kelley, D. E. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.1.166 · Cited by 441
Self-citationKelley, D. E., & Goodpaster, B. H. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.933 · Cited by 406
Self-citationKrook, A., Björnholm, M., Galuska, D., Jiang, X. J., Fahlman, R., Myers, M. G., Wallberg-Henriksson, H., & Zierath, J. R. (2000) · Diabetes · doi:10.2337/diabetes.49.2.284 · Cited by 375
The metabolic syndrome: role of skeletal muscle metabolism.
Stump, C. S., Henriksen, E. J., Wei, Y., & Sowers, J. R. (2006) · Annals of Medicine · doi:10.1080/07853890600888413 · Cited by 362
Björnholm, M., Kawano, Y., Lehtihet, M., & Zierath, J. R. (1997) · Diabetes · doi:10.2337/diab.46.3.524 · Cited by 359
“Thus, in addition to reduced IR kinase activity (7-9), defects in insulin signaling through IRS1 and PI 3-kinase may to contribute to impaired glucose transport (6,14-18) and reduced plasma membrane GLUT4 content in muscle from NIDDM subjects (16,18).”
BackgroundFyfe, J. J., Bishop, D. J., & Stepto, N. K. (2014) · Sports Medicine · doi:10.1007/s40279-014-0162-1 · Cited by 347
Virtanen, K. A., Lönnroth, P., Parkkola, R., Peltoniemi, P., Asola, M., Viljanen, T., Tolvanen, T., Knuuti, J., Rönnemaa, T., Huupponen, R., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3902 · Cited by 315
“In accordance with earlier studies (1, 30, 37), the obese subjects exhibited skeletal muscle insulin resistance and the glucose disposal rate was decreased indicating whole-body insulin resistance (Fig.”
ResultPathophysiology of insulin resistance
Sesti, G. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.09.007 · Cited by 285
Friedman, J. E., Ishizuka, T., Shao, J., Huston, L., Highman, T., & Catalano, P. (1999) · Diabetes · doi:10.2337/diabetes.48.9.1807 · Cited by 255
The role of GSK3 in glucose homeostasis and the development of insulin resistance
Lee, J., & Kim, M.-S. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.033 · Cited by 245
Cline, G. W., Johnson, K., Regittnig, W., Perret, P., Tozzo, E., Xiao, L., Damico, C., & Shulman, G. I. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2903 · Cited by 228
Ryder, J. W., Yang, J., Galuska, D., Rincón, J., Björnholm, M., Krook, A., Lund, S., Pedersen, O., Wallberg-Henriksson, H., Zierath, J. R., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.4.647 · Cited by 216
Hunter, S. J., & Garvey, W. T. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00300-3 · Cited by 200
Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans.
Roden, M., Krssak, M., Stingl, H., Gruber, S., Hofer, A., Fürnsinn, C., Moser, E., & Waldhäusl, W. (1999) · Diabetes · doi:10.2337/diabetes.48.2.358 · Cited by 192
Exercise and insulin cause GLUT-4 translocation in human skeletal muscle
Thorell, A., Hirshman, M. F., Nygren, J., Jorfeldt, L., Wojtaszewski, J. F. P., Dufresne, S. D., Horton, E. S., Ljungqvist, O., & Goodyear, L. J. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.4.e733 · Cited by 191
Baron, A. D., Tarshoby, M., Hook, G., Lazaridis, E. N., Cronin, J., Johnson, A., & Steinberg, H. O. (2000) · Diabetes · doi:10.2337/diabetes.49.5.768 · Cited by 174
Effects of Obesity on Substrate Utilization during Exercise
Goodpaster, B. H., Wolfe, R. R., & Kelley, D. E. (2002) · Obesity Research · doi:10.1038/oby.2002.78 · Cited by 169
Self-citationInsulin signaling and glucose transport in insulin resistant human skeletal muscle
Karlsson, H. K. R., & Zierath, J. R. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0030-9 · Cited by 159
Cellular and Molecular Mechanisms of Non-Insulin Dependent Diabetes Mellitus
Kruszynska, Y. T., & Olefsky, J. M. (1996) · Journal of Investigative Medicine · doi:10.1177/108155899604400806 · Cited by 176
Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
Pendergrass, M., Koval, J., Vogt, C., Yki-Jarvinen, H., Iozzo, P., Pipek, R., Ardehali, H., Printz, R., Granner, D., DeFronzo, R. A., et al. (1998) · Diabetes · doi:10.2337/diabetes.47.3.387 · Cited by 119
Büsing, K. A., Schönberg, S. O., Brade, J., & Wasser, K. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.10.014 · Cited by 111
“Furthermore, decreases in insulin-stimulated glucose uptake in skeletal muscles cells are likely to be caused by an impaired intracellular glucose metabolism [39,40].”
BackgroundThe effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes
Tan, G. D., Fielding, B. A., Currie, J. M., Humphreys, S. M., D�sage, M., Frayn, K. N., Laville, M., Vidal, H., & Karpe, F. (2004) · Diabetologia · doi:10.1007/s00125-004-1619-9 · Cited by 126
“The entry of glucose into muscle cells has been shown to be a major controlling step of glucose disposal in type 2 diabetes [69, 70].”
BackgroundNikolić, N., Görgens, S. W., Thoresen, G. H., Aas, V., Eckel, J., & Eckardt, K. (2017) · Acta Physiologica · doi:10.1111/apha.12830 · Cited by 110
“…have been described such as impaired insulin signalling transduction (Andreasson et al. 1991, Karlsson et al. 2005), reduced insulin-stimulated glucose uptake (Kelley et al. 1996, Krook et al. 2000), and defects in GLUT4 trafficking and translocation (Kelley et al. 1996, Garvey et al. 1998).”
BackgroundMaianu, L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.11.5450 · Cited by 111
Stuart, C. A., Howell, M. E. A., Zhang, Y., & Yin, D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0162 · Cited by 109
Eskian, M., Alavi, A., Khorasanizadeh, M., Viglianti, B. L., Jacobsson, H., Barwick, T. D., Meysamie, A., Yi, S. K., Iwano, S., Bybel, B., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4194-x · Cited by 109
Kugananthan, S., Gridneva, Z., Lai, C. T., Hepworth, A. R., Mark, P. J., Kakulas, F., & Geddes, D. T. (2017) · Nutrients · doi:10.3390/nu9030252 · Cited by 111
“Excessive adipose tissue storage has been shown to impair amino acid and monosaccharide metabolism and transport [37,38], yet increased serum amino acid levels were found in mothers with more adipose tissue [39].”
BackgroundWang, J.-H., Bose, S., Kim, H.-G., Han, K.-S., & Kim, H. (2015) · Scientific Reports · doi:10.1038/srep08391 · Cited by 104
Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice
Kim, J. H., Stewart, T. P., Soltani-Bejnood, M., Wang, L., Fortuna, J. M., Mostafa, O. A., Moustaid-Moussa, N., Shoieb, A. M., McEntee, M. F., Wang, Y., et al. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06647 · Cited by 104
Kelley, D. E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.11.5412 · Cited by 104
“cose metabolism, and PET imaging makes this feasible (13).”
Self-citationLumped constant for [18F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans
Peltoniemi, P., Lönnroth, P., Laine, H., Oikonen, V., Tolvanen, T., Grönroos, T., Strindberg, L., Knuuti, J., & Nuutila, P. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e1122 · Cited by 101
“This method has been widely used to study healthy subjects (36) and, recently, also insulin-resistant subjects (23, 27, 28, 37, 48, 54).”
BackgroundMethodPendergrass, M., Bertoldo, A., Bonadonna, R., Nucci, G., Mandarino, L., Cobelli, C., & DeFronzo, R. A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00617.2005 · Cited by 87
Chiu, H. K., Tsai, E. C., Juneja, R., Stoever, J. A., Brooks‐Worrell, B., Goel, A., & Palmer, J. P. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.12.013 · Cited by 111
Christopher, M., Hew, F. L., Oakley, M., Rantzau, C., & Alford, F. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4836 · Cited by 89
Stolic, M., Russell, A. W., Hutley, L. J., Fielding, G., Hay, J., Macdonald, G. A., Whitehead, J. P., & Prins, J. B. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801850 · Cited by 100
Kinetic modeling of [18F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model
Bertoldo, A., Peltoniemi, P., Oikonen, V., Knuuti, J., Nuutila, P., & Cobelli, C. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.3.e524 · Cited by 86
“The use of compartmental models to describe [18F]FDG kinetics in human skeletal muscle has recently seen important contributions (14, 15, 19, 26, 34).”
BackgroundMethodResultInfluentialExercise and the Treatment of Diabetes and Obesity
O’Gorman, D. J., & Krook, A. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.07.006 · Cited by 101
Behrens, G. M. N., Boerner, A. R., Weber, K. K., van den Hoff, J., Ockenga, J., Brabant, G. E., & Schmidt, R. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15626 · Cited by 90
“This provides a technology for analogous in vivo assessment of glucose transport and phosphorylation (13, 14).”
Regulation of hexokinase II activity and expression in human muscle by moderate exercise
Koval, J. A., DeFronzo, R. A., O’Doherty, R. M., Printz, R., Ardehali, H., Granner, D. K., & Mandarino, L. J. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.274.2.e304 · Cited by 79
“Finally, it is well known that exercise increases insulin sensitivity (2, 3, 5, 12, 17, 23, 30), and it is believed that either glucose transport or hexokinase activities are rate determining under many conditions for glucose uptake into skeletal muscle (8, 24).”
BackgroundSkeletal Muscle Metabolic Dysfunction in Obesity and Metabolic Syndrome
Wells, G. D., Noseworthy, M. D., Hamilton, J., Tarnopolski, M., & Tein, I. (2008) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100007538 · Cited by 78
Anderson, C. M., Hu, J., Barnes, R. M., Heidt, A. B., Cornelissen, I., & Black, B. L. (2015) · Skeletal Muscle · doi:10.1186/s13395-015-0031-0 · Cited by 77
“Insulin resistance leads to decreased insulin signaling and, in turn, to decreased glucose transport into muscle [5].”
BackgroundHaugaard, S. B., Madsbad, S., Høy, C., & Vaag, A. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02444.x · Cited by 76
In vivo measurement of synthesis rate of individual skeletal muscle mitochondrial proteins
Jaleel, A., Short, K. R., Asmann, Y. W., Klaus, K. A., Morse, D. M., Ford, G. C., & Nair, K. S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90586.2008 · Cited by 76
Utriainen, T., Nuutila, P., Takala, T., Vicini, P., Ruotsalainen, U., Rönnemaa, T., Tolvanen, T., Raitakari, M., Haaparanta‐Solin, M., Kirvelä, O., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119591 · Cited by 84
“Regarding the location of the defect in cellular glucose extraction in patients with NIDDM, some investigators have used a three-compartment model for [(18)F]FDG tissue activity to derive rate constants of [(18)F]FDG transport and phosphorylation in skeletal muscle (69, 70).”
MethodRegulation of hepatic and peripheral glucose disposal
Moore, M. C., Cherrington, A. D., & Wasserman, D. H. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(03)00036-8 · Cited by 96
Tong, P. C. Y., Lee, Z. S. K., Sea, M.-M., Chow, C.-C., Ko, G. T. C., Chan, W.-B., So, W.-Y., Ma, R. C. W., Ozaki, R., Woo, J., et al. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.21.2428 · Cited by 72
Hussein, J., El‐Naggar, M. E., Latif, Y. A., Medhat, D., El‐Bana, M. A., Refaat, E., & Morsy, S. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.05.058 · Cited by 71
Lionetti, L., Mollica, M. P., Crescenzo, R., D’Andrea, E., Ferraro, M., Bianco, F., Liverini, G., & Iossa, S. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803636 · Cited by 74
Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes
Williams, K. V., & Kelley, D. E. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00049.x · Cited by 80
Self-citationAdaption of Sprague Dawley rats to long-term feeding of high fat of high fructose diets
Stark, A. H., Timar, B., & Madar, Z. (2000) · European Journal of Nutrition · doi:10.1007/s003940070016 · Cited by 83
Jackson, S., Bagstaff, S. M., Lynn, S., Yeaman, S. J., Turnbull, D. M., & Walker, M. (2000) · Diabetes · doi:10.2337/diabetes.49.7.1169 · Cited by 69
“Previous work has reported normal expression of GLUT4 in type 2 diabetic skeletal muscle (48,49) and cultured human muscle cells (28), but there is evidence of impaired GLUT4 translocation in response to insulin (21,22).”
Fueger, P. T., Hess, H. S., Posey, K. A., Bracy, D. P., Pencek, R. R., Charron, M. J., & Wasserman, D. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408312200 · Cited by 67
Emerging Concepts in the Pathophysiology of Type 2 Diabetes Mellitus
Surampudi, P. N., John‐Kalarickal, J., & Fonseca, V. A. (2009) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20113 · Cited by 95
Effects of blood glucose level on FDG uptake by liver: a FDG-PET/CT study
Kubota, K., Watanabe, H., Murata, Y., Yukihiro, M., Ito, K., Morooka, M., Minamimoto, R., Hori, A., & Shibuya, H. (2011) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.09.004 · Cited by 66
“Also, these mechanisms are deteriorated in non-insulindependent diabetes mellitus and obesity [20].”
BackgroundImpact of Intravenous Insulin on 18F-FDG PET in Diabetic Cancer Patients
Roy, F.-N., Beaulieu, S., Boucher, L., Bourdeau, I., & Cohade, C. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.056283 · Cited by 63
“Kelley et al. found that phosphorylation was altered only in diabetic patients ( 20 ) and that it increased in a dose-responsive manner with insulin infusion (21).”
BackgroundGao, X., Chen, W., Kong, X., Xu, A., Wang, Z. G., Sweeney, G., & Wu, D. (2009) · Diabetologia · doi:10.1007/s00125-009-1284-0 · Cited by 73
“In this regard, the decreased glycogen content in skeletal muscle of Cpt1c KO mice on HFD is likely to be due to decreased insulin-stimulated glycogen synthase activity and glycogen synthesis [39, 40].”
BackgroundBertoldo, A., Vicini, P., Sambuceti, G., Lammertsma, A. A., Parodi, O., & Cobelli, C. (1998) · IEEE Transactions on Biomedical Engineering · doi:10.1109/10.730437 · Cited by 61
“[26] has been used to evaluate microscopic parameters in muscle [12], heart [9], [19], and liver [25] in various pathophysiological conditions.”
MethodInteractions of Impaired Glucose Transport and Phosphorylation in Skeletal Muscle Insulin Resistance
Williams, K. V., Price, J. C., & Kelley, D. E. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2069 · Cited by 61
“In skeletal muscle in lean healthy individuals, insulin enhances the efficiency of glucose phosphorylation (1,6).”
BackgroundMethodSelf-citationINTERACTION OF PHYSIOLOGICAL MECHANISMS IN CONTROL OF MUSCLE GLUCOSE UPTAKE
Wasserman, D. H., & Ayala, J. E. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2005.04191.x · Cited by 59
Muscular response and adaptation to diabetes mellitus
Sun, Z., Liu, L., Liu, N., & Liu, Y. (2008) · Frontiers in bioscience · doi:10.2741/3038 · Cited by 64
“It has been shown that the activity as well as gene expression of hexokinase in the diabetic skeletal muscle is decreased (279, 280).”
BackgroundLerman, R. H., Minich, D. M., Darland, G. K., Lamb, J. J., Schiltz, B., Babish, J. G., Bland, J. S., & Tripp, M. L. (2008) · Nutrition & Metabolism · doi:10.1186/1743-7075-5-29 · Cited by 60
“Acute infusion of free fatty acids leads to the accumulation of TG in skeletal muscle and evokes whole body insulin resistance with the same temporal pattern [16-19].”
BackgroundIozzo, P., Pratipanawatr, T., Pijl, H., Vogt, C., Kumar, V., Pipek, R., Matsuda, M., Mandarino, L. J., Cusi, K. J., & DeFronzo, R. A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e712 · Cited by 57
“INSULIN RESISTANCE IS A CHARACTERISTIC finding in type 2 diabetes mellitus (8) and has been related to abnormalities in insulin receptor signal transduction (16, 31), glucose transport and phosphorylation (3, 21), and glycogen synthesis (2, 44).”
BackgroundPASSCLAIM1?Body weight regulation, insulin sensitivity and diabetes risk
Riccardi, G., Aggett, P. J., Brighenti, F., Delzenne, N. M., Frayn, K. N., Nieuwenhuizen, A. G., Pannemans, D. L. E., Theis, S., Tuijtelaars, S., & Vessby, B. O. (2004) · European Journal of Nutrition · doi:10.1007/s00394-004-1202-7 · Cited by 74
Stanley, T. L., JOY, T. R., Hadigan, C. M., Liebau, J., Makimura, H., Chen, C. Y., Thomas, B. J., Weise, S. B., Robbins, G. K., & Grinspoon, S. K. (2009) · AIDS · doi:10.1097/qad.0b013e32832ba904 · Cited by 55
Targeting glycogen synthase kinase-3 in insulin signalling
Frame, S., & Zheleva, D. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.3.429 · Cited by 54
“In both obesity and Type 2 diabetes, resistance to the effects of insulin has been associated with abnormalities in insulin receptor signal transduction [45,46], glucose transport [47,48] and glycogen synthesis [49,50].”
BackgroundInsulin regulation of glucose transport and phosphorylation in skeletal muscle assessed by PET
Kelley, D. E., Williams, K. V., & Price, J. C. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.2.e361 · Cited by 54
“As this model has not been widely used to investigate skeletal muscle (20, 32), we also sought in the current study to carry out collateral methods to place the findings within a broader context.”
BackgroundMethodResultSelf-citationBell, J. A., Volpi, E., Fujita, S., Cadenas, J. G., Sheffield-Moore, M., & Rasmussen, B. B. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.5.1249 · Cited by 53
“Individuals with type 2 diabetes (T2DM)4 are characterized by hyperinsulinemia and insulin resistance leading to fasting and postprandial hyperglycemia and abnormal fatty acid metabolism (1,2).”
BackgroundLarsen, M. O., Rolin, B., WILKEN, M., Carr, R. D., & Svendsen, O. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04297.x · Cited by 61
Skeletal muscle phosphatidylcholine fatty acids and insulin sensitivity in normal humans
Clore, J. N., Li, J., Gill, R., Gupta, S., Spencer, R., Azzam, A., Zuelzer, W., Rizzo, W. B., & Blackard, W. G. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.4.e665 · Cited by 52
“Recent studies have demonstrated impaired glucose transport (3) and/or phosphorylation (37) in obese diabetic and nondiabetic individuals that is associated with a reduction in the translocation of the insulin-regulated glucose transporter GLUT-4 to the sarcolemma (18).”
BackgroundChen, K., Lawson, M. A., Reiman, E. M., Cooper, A. J. L., Feng, D., Huang, S., Bandy, D. J., Ho, D., Yun, L.-S., & Palant, A. (1998) · IEEE Transactions on Medical Imaging · doi:10.1109/42.700735 · Cited by 52
“The N-13 ammonia kinetic model used in this study was equivalent to the FDG model with [8].”
MethodInfluentialDetermination of the lumped constant for [18F] fluorodeoxyglucose in human skeletal muscle.
Kelley, D. E., Williams, K. V., Price, J. C., & Goodpaster, B. H. (1999) · PubMed · Cited by 57
Self-citationKetogenic Diet: an Endocrinologist Perspective
Kuchkuntla, A. R., Shah, M., Velapati, S. R., Gershuni, V. M., Rajjo, T. I., Nanda, S., Hurt, R. T., & Mundi, M. S. (2019) · Current Nutrition Reports · doi:10.1007/s13668-019-00297-x · Cited by 57
Whytock, K. L., & Goodpaster, B. H. (2025) · Circulation Research · doi:10.1161/circresaha.125.325532 · Cited by 65
Goodpaster, B. H., Bertoldo, A., Ng, J. M., Azuma, K., Pencek, R., Kelley, C. A., Price, J. C., Cobelli, C., & Kelley, D. E. (2013) · Diabetes · doi:10.2337/db13-1249 · Cited by 55
“limiting step in basal glucose uptake (30).”
Self-citationClore, J. N., Harris, P. A., Li, J., Azzam, A., Gill, R. S., Zuelzer, W. A., Rizzo, W. B., & Blackard, W. G. (2000) · Metabolism · doi:10.1016/s0026-0495(00)91455-0 · Cited by 54
Kovalik, J.-P., Slentz, D., Stevens, R. D., Kraus, W. E., Houmard, J. A., Nicoll, J. B., Lea-Currie, Y. R., Everingham, K., Kien, C. L., Buehrer, B. M., et al. (2011) · Diabetes · doi:10.2337/db10-0427 · Cited by 46
“3) contribute to reduced glucose utilization in the obese state (27,28).”
BackgroundRegulation of hexokinase II expression in human skeletal muscle in vivo
Vogt, C., Ardehali, H., Iozzo, P., Yki-Järvinen, H., Koval, J., Maezono, K., Pendergrass, M., Printz, R., Granner, D., DeFronzo, R., et al. (2000) · Metabolism · doi:10.1053/meta.2000.6245 · Cited by 45
Isaksson, B., Strömmer, L., Friess, H., Büchler, M. W., Herrington, M. K., Wang, F., Zierath, J. R., Wallberg‐Henriksson, H., Larsson, J., & Permert, J. (2003) · Pancreas · doi:10.1097/00006676-200303000-00014 · Cited by 48
Glucose uptake and metabolism by cultured human skeletal muscle cells: rate-limiting steps
Perriott, L. M., Kono, T., Whitesell, R. R., Knobel, S. M., Piston, D. W., Granner, D. K., Powers, A. C., & May, J. M. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.1.e72 · Cited by 44
“However, there is evidence from clinical studies (3, 17, 30) and from studies of cultured human muscle cells (14) that glucose phosphorylation by hexokinase also affects the rate of glucose utilization, especially under conditions of high glucose concentrations or stimulation by insulin.”
BackgroundRelationship between insulin sensitivity and in vivo mitochondrial function in skeletal muscle
Sirikul, B., Gower, B. A., Hunter, G. R., Larson-Meyer, D. E., & Newcomer, B. R. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00364.2005 · Cited by 43
Exercise and the Treatment of Diabetes and Obesity
O’Gorman, D. J., & Krook, A. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.06.007 · Cited by 61
Using what is accessible to measure that which is not: Necessity of model of system
Cobelli, C., & Caumo, A. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90360-2 · Cited by 44
Insulin, Muscle Glucose Uptake, and Hexokinase: Revisiting the Road Not Taken
Wasserman, D. H. (2021) · Physiology · doi:10.1152/physiol.00034.2021 · Cited by 55
Joshi, D. M., Patel, J. B., & Bhatt, H. (2021) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-020-00274-3 · Cited by 42
Muthulakshmi, S., & Saravanan, R. (2013) · Biochimie · doi:10.1016/j.biochi.2013.01.018 · Cited by 41
Impact of excess aldosterone on glucose homeostasis in adult male rat
Selvaraj, J., Muthusamy, T., Srinivasan, C., & Balasubramanian, K. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.06.030 · Cited by 38
Renna, L. V., Bosè, F., Iachettini, S., Fossati, B., Saraceno, L., Milani, V., Colombo, R., Meola, G., & Cardani, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184987 · Cited by 42
Effects of 17β-Estradiol and Androgen on Glucose Metabolism in Skeletal Muscle
Inada, A., FUJII, N. L., Inada, O., Higaki, Y., Furuichi, Y., & Nabeshima, Y. (2016) · Endocrinology · doi:10.1210/en.2016-1261 · Cited by 38
Diagnostic imaging in the management of patients with metabolic syndrome
Kim, S. R., & Lerman, L. O. (2017) · Translational research · doi:10.1016/j.trsl.2017.10.009 · Cited by 42
“(18)F-FDG PET imaging in skeletal muscle also showed impaired glucose transport in type 2 diabetes and obesity, and impairment of glucose phosphorylation in type 2 diabetes.(50) Because these PET studies used compartmental modeling originally designed for brain studies,(51) dynamic PET imaging has been subsequently de…”
Metadata
- Authors
- Kelley, D. E., Mintun, M. A., Watkins, S. C., Simoneau, J. A., Jadali, F., Fredrickson, A., Beattie, J., & Thériault, R.
- Affiliations
- University of Pittsburgh (US)
- United States Department of Veterans Affairs (US)
- Université Laval (CA)
- Venue
- Journal of Clinical Investigation
- Published
- 1996-06-15
- Volume
- 97
- Issue
- 12
- Pages
- 2705-2713
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507362
- OpenAlex
- W2069960997
- Cited by
- 228
- References
- 58
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 7 · 2016: 9 · 2015: 4 · 2014: 3 · 2013: 7 · 2012: 8
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Université Laval
- University of Pittsburgh
- National Institutes of Health (5p30dk046204-15)
- National Institute of Diabetes and Digestive and Kidney Diseases (1P30DK-46204)
- National Center for Research Resources (M01RR000056, 5 MO1 RR 00056)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- type 2 diabetes, obesity, insulin resistance, skeletal muscle, glucose transport, glucose phosphorylation, GLUT4 translocation, hexokinase, citrate synthase, FDG uptake, insulin-stimulated glucose uptake
- MeSH terms
- Adult, Biological Transport, Citrate (si)-Synthase, Diabetes Mellitus, Type 2, Glucose, Hexokinase, Humans, Insulin, Middle Aged, Monosaccharide Transport Proteins, Muscle Proteins, Obesity, Phosphorylation, Tomography, Emission-Computed, Muscle, Skeletal, Glucose Transporter Type 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.